Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Concentrix (CNXC) EBITDA (2020 - 2025)

Historic EBITDA for Concentrix (CNXC) over the last 6 years, with Q4 2025 value amounting to -$1.4 billion.

  • Concentrix's EBITDA fell 105642.54% to -$1.4 billion in Q4 2025 from the same period last year, while for Nov 2025 it was -$918.2 million, marking a year-over-year decrease of 25395.76%. This contributed to the annual value of -$918.2 million for FY2025, which is 25395.76% down from last year.
  • As of Q4 2025, Concentrix's EBITDA stood at -$1.4 billion, which was down 105642.54% from $147.0 million recorded in Q3 2025.
  • Concentrix's 5-year EBITDA high stood at $180.4 million for Q4 2023, and its period low was -$1.4 billion during Q4 2025.
  • Over the past 5 years, Concentrix's median EBITDA value was $152.3 million (recorded in 2021), while the average stood at $77.6 million.
  • In the last 5 years, Concentrix's EBITDA surged by 44378.29% in 2021 and then crashed by 105642.54% in 2025.
  • Quarter analysis of 5 years shows Concentrix's EBITDA stood at $157.9 million in 2021, then rose by 12.72% to $178.0 million in 2022, then increased by 1.38% to $180.4 million in 2023, then dropped by 19.9% to $144.5 million in 2024, then crashed by 1056.43% to -$1.4 billion in 2025.
  • Its last three reported values are -$1.4 billion in Q4 2025, $147.0 million for Q3 2025, and $148.3 million during Q2 2025.